FDA Approves Vyalev (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson's Disease NORTH CHICAGO, Ill., Oct. 17, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved Vyalev (foscarbidopa and fos...
Press Releases Pharmaceutical CDMO Market Size to Surpass USD 368.70 Bn By 2034 December 17, 2024 · 13 min read Press Releases Viral Vector Production (Research-use) Market Size to Hit USD 7.62 Bn by 2034 December 17, 2024 · 1 min read ...
with his father having died from complications of Wolff-Parkinson-White syndrome. Cardiovascular examination revealed an S3 heart sound and elevated brain natriuretic peptide levels at 875 pg/ml, with undetectable troponins; potassium level on admission was 3.6 mEq/l. An electrocardiogram showed normal...
Myelin and Alzheimer’s disease Rebecca Wright Research Highlights01 Dec 2023Nature Neuroscience Volume: 26, P: 2048 Insights into senolytic drugs for the treatment of SARS-CoV-2 infection in the brain Senescent cells in the brain contribute to age-related neurodegeneration. Analysis of SARS-CoV-2...
Costa Rica had become an "enormous warehouse" of drugs and an operations center for exports to Europe, authorities said. Apr 1, 2023 Gold's Gym owner among 6 feared dead after plane crash off Costa Rica The bodies of one adult and one child have been found, but they have not yet been...
Parkinson's & Movement disorders Parkinson's drug changes the gut microbiome for the worse due to iron deficiency, study reveals A new study has revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency. ...
Parkinson's disease is the world's fastest growing neurological condition. Currently there are no drugs or therapies that slow or stop the progression of the disease. Jul 23, 2024 0 21 Medications Q&A: How future medications could be personalized on a 3D printer ...